How do you pay?

How to pay the least

Cash price

$4,580+ for 30 tablets

Pharmacies pay about this for Mavyret; you’d pay more.

  1. Ask your pharmacy for Mavyret’s cash price, and one or two other pharmacies too.
  2. Mavyret’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify myAbbVie Assist. Our income guidelines are based on the size of your household and annual income. Or call 1-800-222-6885.

See if you qualify 

No generic is sold yet.

Compare every option

Question
Brand nameMavyret
Authorized genericglecaprevir and pibrentasvir
Regular genericglecaprevir and pibrentasvir
What you’d pay
At least$4,580for 30 tablets; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Mavyret?
The original
–
–

Brand nameThe maker’s card

MAVYRET Savings Card

Savings card from AbbVie

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $5 a month

The card takes up to $12,000 in total off your co-pay.

Print the card (PDF) 

Or call 1-877-628-9738. See the offer on mavyret.com

In the maker’s words

“People with commercial insurance may pay as little as $5 per month with the MAVYRET Savings Card.”

From the maker’s offer on mavyret.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Mavyret itself, from the same company, sold without the brand name, and usually for less. For now Mavyret is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says
  • MAVYRET is a fixed-dose combination of glecaprevir, a hepatitis C virus (HCV) NS3/4A protease inhibitor, and pibrentasvir, an HCV NS5A inhibitor, and is indicated for the treatment of adult and pediatric patients 3 years and older with acute or chronic HCV genotype (GT) 1, 2, 3, 4, 5 or 6 infection without cirrhosis or with compensated cirrhosis (Child-Pugh A).
  • MAVYRET is indicated for the treatment of adult and pediatric patients 3 years and older with HCV genotype 1 infection, who previously have been treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor, but not both.

Source: the FDA label for Mavyret (AbbVie Inc.), June 25, 2025. Full label on DailyMed 

Good to know